On Jun. 20, 2025, LOU LEG reported governor signed bill into law, assigned Act 388.
On Jun. 10, LOU LEG passed bill regarding treatment for rare cancers.
LOU LEG passed bill HB 622 to enact LOU INS 22:1076.1 re rare cancers treatment.
Bill Provisions
Creates an advisory board within LOU INS that requires the advisory board to review and provide medical recommendations to approve new treatments for rare cancers.
Provides for the board's composition; to require reporting; to authorize rulemaking.
Board will hold quarterly public meetings; within 30-days of each meeting the board will compile a report of findings and submit a formal written report to the legislature.
Legislative History
On Apr. 4, 2025, bill introduced in House; on May 21, 2025, bill passed in the House.
On May 21, 2025, bill introduced in Senate; on Jun. 9, 2025, amended bill passed.
On Jun. 9, 2025, House received amended bill; on Jun. 10, 2025, House concurred.
Effectiveness
If an effective date is not provided in the bill text, the bill will always become effective on Aug. 1 of the year that the bill passed the Legislature, so effective on Aug. 1, 2025.
Jun. 20, 2025 LOU LEG Governor Approval
On Jun. 20, 2025, LOU LEG reported governor signed bill into law, assigned Act 388.
Regulators
LOU LEG
Entity Types
Ins
Reference
Act 388, 6/20/2025; Bill HB622, 6/10/2025; Citation: LOU INS 22:1076.1;
